Paper3325929
Ciprofloxacin for infection prevention in patients with acute leukemia.
Rozenberg-Arska M and 1 other. Pharm Weekbl Sci, 1987. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. Ciprofloxacin for infection prevention in patients with acute leukemia. Papers, record 3325929. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3325929
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bacterial Infections | Major topic |
| Ciprofloxacin | Major topic |
| Leukemia | Major topic |
| Adult | |
| Clinical Trials as Topic | |
| Colistin | |
| Drug Combinations | |
| Drug Therapy, Combination | |
| Humans | |
| Random Allocation | |
| Sulfamethoxazole | |
| Trimethoprim | |
| Trimethoprim, Sulfamethoxazole Drug Combination |
Source PubMed
References15
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 6842003 | Selective antimicrobial modulation as prophylaxis against infection during granulocytopenia: trimethoprim-sulfamethoxazole vs. nalidixic acid. | J Infect Dis | 1983 | https://conductscience.org/library/papers/6842003 | PubMed |
| 2 | 3159811 | Ciprofloxacin for selective decontamination of the alimentary tract in patients with acute leukemia during remission induction treatment: the effect on fecal flora. | J Infect Dis | 1985 | https://conductscience.org/library/papers/3159811 | PubMed |
| 3 | 3010716 | Norfloxacin versus vancomycin/polymyxin for prevention of infections in granulocytopenic patients. | Am J Med | 1986 | https://conductscience.org/library/papers/3010716 | PubMed |
| 4 | 6842001 | Antimicrobial prophylaxis against infection in neutropenic patients. | J Infect Dis | 1983 | https://conductscience.org/library/papers/6842001 | PubMed |
| 5 | 6794406 | Prevention of infection by trimethoprim-sulfamethoxazole plus amphotericin B in patients with acute nonlymphocytic leukaemia. | Ann Intern Med | 1981 | https://conductscience.org/library/papers/6794406 | PubMed |
| 6 | 3466563 | Infection prophylaxis in acute leukemia: a comparison of ciprofloxacin with trimethoprim-sulfamethoxazole and colistin. | Ann Intern Med | 1987 | https://conductscience.org/library/papers/3466563 | PubMed |
| 7 | 6997054 | Infection prevention in granulocytopenic patients by selective decontamination of the digestive tract. | Eur J Cancer (1965) | 1980 | https://conductscience.org/library/papers/6997054 | PubMed |
| 8 | 4206836 | Selective elimination of Enterobacteriaceae species from the digestive tract in mice and monkeys. | J Hyg (Lond) | 1974 | https://conductscience.org/library/papers/4206836 | PubMed |
| 9 | 4628214 | Origin of infection in acute nonlymphocytic leukemia. Significance of hospital acquisition of potential pathogens. | Ann Intern Med | 1972 | https://conductscience.org/library/papers/4628214 | PubMed |
| 10 | 6660852 | Pharmacokinetics and tissue penetration of ciprofloxacin. | Antimicrob Agents Chemother | 1983 | https://conductscience.org/library/papers/6660852 | PubMed |
| 11 | 6222695 | In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agents. | Antimicrob Agents Chemother | 1983 | https://conductscience.org/library/papers/6222695 | PubMed |
| 12 | 6222896 | In vitro activity of ciprofloxacin, norfloxacin and nalidixic acid. | Eur J Clin Microbiol | 1983 | https://conductscience.org/library/papers/6222896 | PubMed |
| 13 | 6604030 | Colistin and trimethoprim-sulfamethoxazole for the prevention of infection in patients with acute non-lymphocytic leukaemia. Decrease in the emergence of resistant bacteria. | Infection | 1983 | https://conductscience.org/library/papers/6604030 | PubMed |
| 14 | 6339052 | Strategies for the prevention of infection in the myelosuppressed or immunosuppressed cancer patient. | Cancer Treat Rep | 1983 | https://conductscience.org/library/papers/6339052 | PubMed |
| 15 | 6140347 | The quinolones. | Lancet | 1984 | https://conductscience.org/library/papers/6140347 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 24706220 | Host impairments in patients with neoplastic diseases. | Cancer Treat Res | 2014 | https://conductscience.org/library/papers/24706220 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3325929
GET https://conductscience.org/api/papers/v1/3325929/authors